ImmunityBio IBRX
NASDAQ IBRX
$10.28 +1.00 (+10.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Asset Writedowns and Impairment (2019 - 2023)

Updated

ImmunityBio (IBRX) posted Asset Writedowns and Impairment of $14.02 million for FY2025.

Analysis

ImmunityBio (IBRX) Asset Writedowns and Impairment (2019 - 2023) Analysis & Trends

Since FY2019, ImmunityBio has reported Asset Writedowns and Impairment for 5 years.

  • Annual Asset Writedowns and Impairment shows a five-year compound annual growth rate of 5.6% (FY2020 to FY2025).
  • The FY2025 figure stands as the highest annual Asset Writedowns and Impairment in data going back to FY2019.
  • Business Quant data shows IBRX's Asset Writedowns and Impairment at $886,000 in FY2023 (-33.5%) and $1.33 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 ImmunityBio 10.83 Bn 9.59 Bn 50.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 886,000.00
Dec 31, 2022 652,000.00
Dec 31, 2020 40,000.00
Sep 30, 2020 10.66 Mn
Dec 31, 2019 724,000.00
API Access

ImmunityBio Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IBRX&period=max&api_key=YOUR_API_KEY